HalioDx is Now Part of Veracyte! Learn About HalioDx Read the Press Release
Search Tool Menu
HalioDx is Now Part of Veracyte! Learn About HalioDx Read the Press Release
Menu
Close Button

Transforming Cancer Diagnostics

Bonnie Anderson, Cofounder and Executive Chairwoman, on what it takes to make a meaningful and lasting impact on cancer diagnostics, and how advanced technology today can help save lives tomorrow.

Accelerating Answers,
Improving Outcomes

Veracyte is committed to transforming the patient experience in 8 of the top 10 cancers (by incidence in the United States). At every step of the patient journey, we are innovating to prevent unnecessary surgeries and accelerate time to appropriate treatment.

Learn more about Veracyte’s oncology products.

Breast Cancer

Using prognostic information to inform next steps in patient care

Learn More >

Lung Cancer

Providing answers at every step of the patient journey

Learn More >

Prostate Cancer

Providing clarity and confidence in treatment planning

Learn More >

Thyroid Cancer

Reducing unnecessary surgeries and informing treatment decisions in thyroid cancer diagnosis

Learn More >

Improving the Lung Cancer Journey

Breaking News:
New Data to Be Presented at ASCO 2021 Show Early Lung Cancer Detection Can Be Improved with Simple Nasal Swab

Learn More >
latest news